Literature DB >> 10889495

Endoscopic CO2 laser excision for tis, T1, and T2 glottic carcinomas: cure rate and prognostic factors.

G Peretti1, P Nicolai, L O Redaelli De Zinis, M Berlucchi, T Bazzana, F Bertoni, A R Antonelli.   

Abstract

We present the results of a retrospective study based on a cohort of 140 patients who underwent endoscopic CO(2) laser excision for previously untreated early glottic cancer (21 Tis, 96 T1, and 23 T2). This study used univariate analysis to review the impact on disease-free survival of 15 factors related to the host, the tumor, and the treatment. Recurrent cancer developed in 28 patients with an average interval to recurrence of 37.5 months. Retreatment consisted of different procedures, including laser excision, partial or total laryngectomy, and/or radiotherapy. The larynx was definitively preserved in 96% of patients. By the end of the study, 14 patients had died, but only 2 of them had died of the disease. Five-year overall survival and determinate survival were 93% and 98%, respectively. Ultimate local control at 5 years with CO(2) laser excision alone was 95% for Tis, 87% for T1, and 91% for T2 lesions. Only involvement of the anterior third of the vocal cord (P = 0.02), involvement of the false vocal cord (P = 0.02), and infiltration of the vocalis muscle (P = 0.004) showed a significant negative impact on disease-free survival.

Entities:  

Mesh:

Year:  2000        PMID: 10889495     DOI: 10.1067/mhn.2000.104523

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  29 in total

1.  Oncological outcome after CO2 laser cordectomy for early-stage glottic carcinoma.

Authors:  C Bocciolini; L Presutti; P Laudadio
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

3.  Management of surgical margins after endoscopic laser surgery for early glottic cancers: a multicentric evaluation in French-speaking European countries.

Authors:  Nicolas Fakhry; Sébastien Vergez; Emmanuel Babin; Karine Baumstarck; Laure Santini; Patrick Dessi; Antoine Giovanni
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-11       Impact factor: 2.503

4.  Medialization thyroplasty for voice restoration after transoral cordectomy.

Authors:  Nicholas S Mastronikolis; Marc Remacle; Debora Kiagiadaki; George Lawson; Vincent Bachy; Sebastien Van Der Vorst
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-02       Impact factor: 2.503

5.  Impact of resection margin status on oncological outcomes after CO2 laser cordectomy.

Authors:  P Aluffi Valletti; F Taranto; A Chiesa; F Pia; G Valente
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-05-22       Impact factor: 2.124

6.  CO₂ laser cordectomy for T1-T2 glottic cancer: oncological and functional long-term results.

Authors:  Giulia Bertino; Giulia Degiorgi; Carmine Tinelli; Salvatore Cacciola; Antonio Occhini; Marco Benazzo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-21       Impact factor: 2.503

7.  Glottic laser surgery: outcomes according to 2007 ELS classification.

Authors:  Marco Lucioni; Gino Marioni; Andy Bertolin; Luciano Giacomelli; Giuseppe Rizzotto
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-19       Impact factor: 2.503

8.  Long Term Oncological Results of Transoral Laser Microsurgery for Early and Moderately Advanced Glottic Carcinoma in Primary and Salvage Settings.

Authors:  Prem Sagar; Rajeev Kumar; Richa Vaish; Alok Thakar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-29

9.  Thyroarytenoid muscle invasion in T1 glottic carcinoma.

Authors:  B Pittore; H Ismail-Koch; A Davis; G Parodo; G P Ledda; P A Brennan; R Puxeddu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

10.  Pre- and intraoperative assessment of mid-cord erythroleukoplakias: a prospective study on 52 patients.

Authors:  Giorgio Peretti; Cesare Piazza; Marco Berlucchi; Johnny Cappiello; Marco Giudice; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.